Publications by authors named "Rajesh Devraj"

Claim this Profile
P
Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy.
Todd Bosanac, Robert O Hughes, Thomas Engber, Rajesh Devraj, Andrew Brearley

Brain· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small Molecule SARM1 Inhibitors Recapitulate the SARM1 Phenotype and Allow Recovery of a Metastable Pool of Axons Fated to Degenerate.
Robert O Hughes, Todd Bosanac, Xianrong Mao, Thomas M Engber, Aaron DiAntonio, Rajesh Devraj

Cell Rep· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons.
Yo Sasaki, Thomas M Engber, Robert O Hughes, Matthew D Figley, Tong Wu, Rajesh Devraj

Exp Neurol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axons Matter: The Promise of Treating Neurodegenerative Disorders by Targeting SARM1-Mediated Axonal Degeneration.
Raul Krauss, Todd Bosanac, Rajesh Devraj, Thomas Engber, Robert O Hughes

Trends Pharmacol Sci· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and characterization of atropisomer PH-797804, a p38 MAP kinase inhibitor, as a clinical drug candidate.
Li Xing, Balekudru Devadas, Rajesh V Devraj, Shaun R Selness, Huey Shieh

ChemMedChem· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of INCB8761/PF-4136309, a Potent, Selective, and Orally Bioavailable CCR2 Antagonist.
Chu-Biao Xue, Anlai Wang, Qi Han, Yingxin Zhang, Ganfeng Cao, Rajesh Devraj

ACS Med Chem Lett· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substituted N-aryl-6-pyrimidinones: a new class of potent, selective, and orally active p38 MAP kinase inhibitors.
Balekudru Devadas, Shaun R Selness, Li Xing, Heather M Madsen, Laura D Marrufo, Rajesh V Devraj

Bioorg Med Chem Lett· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and activity of a potent, selective series of N-aryl pyridinone inhibitors of p38 kinase.
Shaun R Selness, Terri L Boehm, John K Walker, Balekudru Devadas, Richard C Durley, Rajesh V Devraj

Bioorg Med Chem Lett· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinase.
Shaun R Selness, Rajesh V Devraj, Balekudru Devadas, John K Walker, Terri L Boehm

Bioorg Med Chem Lett· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of ((1S,3R)-1-isopropyl-3-((3S,4S)-3-methoxy-tetrahydro-2H-pyran-4-ylamino)cyclopentyl)(4-(5-(trifluoromethyl)pyridazin-3-yl)piperazin-1-yl)methanone, PF-4254196, a CCR2 antagonist with an improved cardiovascular profile.
Robert O Hughes, D J Rogier, Rajesh Devraj, Changsheng Zheng, Ganfeng Cao

Bioorg Med Chem Lett· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of INCB10820/PF-4178903, a potent, selective, and orally bioavailable dual CCR2 and CCR5 antagonist.
Changsheng Zheng, Ganfeng Cao, Michael Xia, Hao Feng, Joseph Glenn, Rajesh Devraj

Bioorg Med Chem Lett· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of novel CCR2 antagonists: investigation of non-aryl/heteroaryl binding motifs.
John I Trujillo, Wei Huang, Robert O Hughes, D Joseph Rogier, Steven R Turner, Rajesh Devraj

Bioorg Med Chem Lett· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute lymphoid and gastrointestinal toxicity induced by selective p38alpha map kinase and map kinase-activated protein kinase-2 (MK2) inhibitors in the dog.
Dale L Morris, Shawn P O'Neil, Rajesh V Devraj, Joseph P Portanova, Richard W Gilles

Toxicol Pathol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 5-substituted-N-arylpyridazinones as inhibitors of p38 MAP kinase.
Kevin D Jerome, Michael E Hepperle, John K Walker, Li Xing, Rajesh V Devraj

Bioorg Med Chem Lett· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of SD-0006, a potent diaryl pyrazole inhibitor of p38 MAP kinase.
John K Walker, Shaun R Selness, Rajesh V Devraj, Michael E Hepperle, Win Naing

Bioorg Med Chem Lett· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translation.
Heidi R Hope, Gary D Anderson, Barry L Burnette, Robert P Compton, Rajesh V Devraj

J Pharmacol Exp Ther· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of N-substituted pyridinones as potent and selective inhibitors of p38 kinase.
Shaun R Selness, Rajesh V Devraj, Joseph B Monahan, Terri L Boehm, John K Walker

Bioorg Med Chem Lett· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural bioinformatics-based prediction of exceptional selectivity of p38 MAP kinase inhibitor PH-797804.
Li Xing, Huey S Shieh, Shaun R Selness, Rajesh V Devraj, John K Walker

Biochemistry· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physiochemical drug properties associated with in vivo toxicological outcomes.
Jason D Hughes, Julian Blagg, David A Price, Simon Bailey, Gary A Decrescenzo, Rajesh V Devraj

Bioorg Med Chem Lett· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, crystal structure, and activity of pyrazole-based inhibitors of p38 kinase.
Matthew J Graneto, Ravi G Kurumbail, Michael L Vazquez, Huey-Sheng Shieh, Jennifer L Pawlitz, Rajesh Devraj

J Med Chem· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis